Business - Briefly   

Granules India gets European audit nod

HYDERABAD: Granules India's new pharmaceutical formulations intermediates (PFI) plant at Gagillapur, one of the largest in the world with a 7,200 tonnes per annum capacity, has successfully gone through its first international regulatory audit by the German Health Authority. According to a release issued here on Tuesday, with this approval, the company can export its products to Europe from this facility. The company is also looking forward to similar approvals from other international regulatory bodies such as the Australian TGA, and U.S. FDA, said N. R. Ganti, Director.

Our Special Correspondent

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts: Classifieds | Employment | Obituary | Updates: Breaking News |

Stories in this Section

• Gartner sees higher telecom growth in Asia
• Wipro's Q3 net up 19 p.c. at Rs. 274 crores
• Patni fixes price band for IPO
• Oil refining, steel spur infrastructure growth
• Rising euro threatens euro zone recovery
• Further steep fall in Sensex
• Rupee edges up
• VSNL third quarter net up
• Ranbaxy forays into herbal products market
• Indian Bank to distribute UTI MF products
• SIAM, ACMA tie-up with world body
• Stock Market Index
• Bullion rates
• Exchange rates
• GAIL, ONGC to file draft prospectus
• Fitch upgrades India's rating
• Mega offer from Bru/Deluxe Green Label
• NeST group diversifies
• Granules India gets European audit nod
• Spartek group plans JV
• OVL to take 11 p.c. stake in Sudan oil field
• Syndicate Bank ties up with Punjab Tractors
• Bajaj Capital expands
• Bank of Punjab pact with SafeScrypt

Copyright © 2004, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu